x.com/COVID19_diseas… $TRAW Pharma 👀 #tivoxavir marboxil is comming

$TRAW pre approval so volatility expected but I am hopeful on their antiviral - I don't see specific news for today

BREAKING NEWS! Tivoxavir Marboxil - The Prophylactic Flu Drug American Agencies and Elites Are Claimed to be Hoarding in Secrecy! thailandmedical.news/news/tivoxavir… #Flu #Influenza #H5N1 #H3N2 #H1N1 #Prophylactic #BreakingNews #News #BREAKING #Pandemic #Drugs #Antiviral #Meds #WorldNews

Tivoxavir Marboxil (TXM), developed by Traws Pharma, and accelerated by Expert Systems’ AI-powered discovery platform, targets the CAP-dependent endonuclease (CEN) enzyme—one of the most highly conserved and essential viral proteins across influenza strains.

x.com/i/status/19990… $TRAW TRAWS PHARMA 👀👀 FDA 's comming

thailandmedical.news/news/tivoxavir… $TRAW TRAWS PHARMA #h5n1 tivoxavir marboxil #blockbuster is comming 👀

thailandmedical.news/news/tivoxavir… $TRAW traws pharma 👀👀👀 #H5N1 #AVIANFLU drug 👇

thailandmedical.news/news/tivoxavir… $TRAW #H5N1 Drug secret phase 2 #BARDA #FDA Potential blockbuster

$TRAW Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients globenewswire.com/news-release/2…

$TRAW Positive Interim Results: On December 17, 2025, Traws Pharma, Inc. announced positive interim data from its Phase 2 study for ratutrelvir, a new COVID treatment. stockinsights.ai/us/TRAW/8-K/ex…

Exciting news from Traws Pharma $TRAW! Positive interim data on ratutrelvir vs. PAXLOVID™ shows promise in treating COVID-19. #Healthcare #Innovation 📈 💡 Seen it? Spread it! Smash 🔁 & ❤️! notdumbmoney.com/traw/202512171…

$TRAW COVID-19 Treatment Update: On January 26, 2026, Traws Pharma, Inc. announced the completion of its study on ratutrelvir for treating COVID-19 and its plans for using tivoxavir marboxil for seasonal influenza prevention. stockinsights.ai/us/TRAW/8-K/ex…

$TRAW Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza More Info: pryzm.ozmosi.com/product/21086

$TRAWS #TRAW PHARMA #H5NA news updated 👇

Hey this is pretty exciting! Traws Pharma is developing a new anti-SARS-CoV-2 antiviral called Ratutrelvir, as a possible alternative to Paxlovid. They just completed enrollment for their Phase 2 clinical trial, and interim results suggest a benefit! Pretty exciting news

$TRAWS #TRAW PHARMA #H5NA news updated 23/1 #BARDA IND COMMING !!! 👇 adisinsight.springer.com/drugs/800077869

x.com/i/status/20158… #BARDA #H5N1 IS COMMING !!! $TRAW PHARMA

$traw covid treatment phase 2 and their txm is a one time dose treatment for bird flu or prophylactic for flu … youtube.com/shorts/RZiURDL…